Role of High Omega-6 Diet as a Risk Factor for Pain Through Increased TRPV1 and TRPA1 Activity

高 Omega-6 饮食通过增加 TRPV1 和 TRPA1 活性作为疼痛的危险因素

基本信息

项目摘要

Abstract Physicians recommend dietary interventions for management of cardiovascular disease, diabetes and many autoimmune diseases; however, there is a large gap in knowledge on the role of diet as a risk factor or potential therapy for chronic pain. Management of pain remains a substantial medical problem, in part, because of an incomplete understanding of the physiologic mechanisms for transduction and processing of noxious stimuli. Moreover, current analgesics are often limited by incomplete efficacy, unacceptable side effects or risk of dependency. New discoveries for both the treatment and prevention of chronic pain are essential, and investigating the relationship between diet and pain allows for the potential development of new therapies along with a better understanding of the mechanisms of persistent pain. Multiple studies have demonstrated that oxidized metabolites of linoleic acid (LA) or arachidonic acid (AA) have potent biological actions in activating transient receptor potential (TRP) channels, including TRPV1 and TRPA1, that are expressed on nociceptive neurons. Since LA and AA are essential omega-6 polyunsaturated fatty acids (PUFA), their physiologic levels are a function of dietary intake. Preliminary data presented in this application demonstrate that mice fed a 15-week high omega-6 diet exhibit changes in basal thermal and mechanical nociceptive thresholds and increased responses to noxious stimuli. However, there is still a large gap in knowledge as the mechanisms by which dietary omega-6 lipid intake modulate pain is not understood. Based on recent studies and our preliminary data, we propose to test the central hypothesis that increased dietary omega-6 PUFA leads to increased thermal hyperalgesia and mechanical allodynia via increased TRPV1 and TRPA1 activities. Diet-induced increased TRPV1 and TRPA1 activity could be a common mechanism among multiple chronic pain conditions and play a role in the transition from acute to chronic pain. The following aims will test the hypothesis: Specific Aim #1: Assess cellular lipid composition change following a 15-week high omega-6 diet and determine the role of the lipids in thermal and mechanical nociception. Specific Aims #2: Investigate the role of TRPV1 and TRPA1 in increased thermal and mechanical nociception following a high omega-6 diet. Specific Aim #3: Determine whether high lipid diet alters nociception in a sex-specific manner. This study is innovative in its rationale and potential for identifying an environmental factor that could predispose and possibly predict pain response. This project may also lead to novel therapeutic approaches for treatment and prevention of chronic pain conditions. Moreover, the techniques and research methods provide an ideal training vehicle for my career as an academic physician-scientist.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JACOB TYLER BOYD其他文献

JACOB TYLER BOYD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
  • 批准号:
    10641500
  • 财政年份:
    2023
  • 资助金额:
    $ 3.41万
  • 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
  • 批准号:
    10485593
  • 财政年份:
    2023
  • 资助金额:
    $ 3.41万
  • 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
  • 批准号:
    10728526
  • 财政年份:
    2023
  • 资助金额:
    $ 3.41万
  • 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
  • 批准号:
    10638278
  • 财政年份:
    2023
  • 资助金额:
    $ 3.41万
  • 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
  • 批准号:
    10621646
  • 财政年份:
    2023
  • 资助金额:
    $ 3.41万
  • 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
  • 批准号:
    22K19602
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10425794
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
  • 批准号:
    10512672
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
  • 批准号:
    10821681
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
  • 批准号:
    10721752
  • 财政年份:
    2022
  • 资助金额:
    $ 3.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了